IDS and Scheie syndrome: The gold standard for the diagnosis of MPS I and MPS II relies on the deficiency of IDUA and IDS activity in leukocytes, fibroblasts, or plasma with an unusual clinical presentation or a phenotype finding that does not match the results of GAG testing [55].